CDC and FDA Joint Telebriefing on Investigation of Meningitis Outbreak
What
CDC and FDA will host a telephone-only media availability to discuss information about the multi-state investigation of meningitis among patients who have received epidural steroid injections.
When
Thursday, October 4 at 2 p.m. ET
Who
CDC, Benjamin Park, MD, medical officer, Mycotic Diseases Branch, Division of Foodborne, Waterborne, and Environmental Diseases, National Center for Emerging and Zoonotic Infectious Diseases
FDA, Ilisa Bernstein, PharmD, JD, director, Office of Compliance, Center for Drug Evaluation and Research
Dial-In
* Please dial in 10 to 15 minutes before the start of the press conference.
DIAL-IN: Media: 888-795-0855 Non-Media: 800-779-0740 INTERNATIONAL: 415-228-4996 PASSCODE: Meningitis
Important Instructions If you would like to ask a question during the call, press *1 on your touchtone phone. Press *2 to withdraw your question. You may queue up at any time. You will hear a tone to indicate your question is pending.
Transcript
A transcript of this press conference will be available following the briefing at www.cdc.gov/media.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
